Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
Celgene
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Columbia University
Wake Forest University Health Sciences
Medical College of Wisconsin
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
New York Medical College
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Columbia University